ENDO: Coffee Does Not Impede Bioavailability of LT4 Solution
FRIDAY, June 17, 2022 -- Bioavailability is equivalent for a single oral dose of levothyroxine (LT4) sodium solution administered five minutes prior to coffee or under fasting conditions, according to a study presented at the annual meeting of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 17, 2022 Category: Pharmaceuticals Source Type: news

Hypothyroidism: No More Wait to Eat or Drink With Liquid Thyroxine? Hypothyroidism: No More Wait to Eat or Drink With Liquid Thyroxine?
Two manufacturers of liquid levothyroxine products now have data showing that patients with hypothyroidism could take these formulations and then avoid the required wait of 30 minutes to eat or drink.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 15, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Debate Continues on Combination Therapy for Hypothyroidism Debate Continues on Combination Therapy for Hypothyroidism
Clinicians shouldn ' t dismiss patients who complain about residual symptoms despite TSH normalization with levothyroxine, say thyroid experts who have rekindled a long-running debate at the AACE meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 20, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Normalized Hypothyroidism Linked With Improved Kidney Function Normalized Hypothyroidism Linked With Improved Kidney Function
Among patients with hypothyroidism but normal kidney function, proteinuria and serum creatinine levels were decreased, and eGFR was increased after levothyroxine-produced euthyroidism in a small study.First Look (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 18, 2022 Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news

Palliative Care in Assisted Living
Mrs. M is a 92-year-old woman residing in an assisted living community. Her medical history includes hypertension, gout, hyperlipidemia, atrial fibrillation, hypothyroidism, and melanoma with invasion into the parotid gland; she has had removal of a lesion and a parotidectomy with nerve involvement impacting the 7th cranial nerve. Her medications include oral levothyroxine, 100 μg daily; oral vitamin D, 1,000 units daily; oral probenecid 500/colchicine, 0.5 mg daily; oral lisinopril, 5 mg daily; oral furosemide, 20 mg daily; oral duloxetine, 60 mg for depression; oral carvedilol, 6.25 mg twice a day; oral aspirin, 81 mg d...
Source: Caring for the Ages - March 29, 2022 Category: Health Management Authors: Barbara Resnick, Paige Hector Tags: Interdisciplinary Team Case Studies Source Type: news

No Change in TSH Level Seen With Switch in Generic LT4 Products
THURSDAY, March 17, 2022 -- Switching among generic levothyroxine products made by different manufacturers is not associated with clinically significant changes in serum thyrotropin (TSH) levels, according to a study published online Feb. 28 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 17, 2022 Category: Pharmaceuticals Source Type: news

levothyroxine
Title: levothyroxineCategory: MedicationsCreated: 3/15/2022 12:00:00 AMLast Editorial Review: 3/15/2022 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - March 15, 2022 Category: Endocrinology Source Type: news

Delays and TSH Among Levothyroxine Patients During COVID-19 Delays and TSH Among Levothyroxine Patients During COVID-19
Many patients needed to delay follow-up visits due to the COVID-19 pandemic. How did these delays impact TSH levels among patients receiving levothyroxine therapy?Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Calcitriol and Levothyroxine for Pseudohypoparathyroidism Calcitriol and Levothyroxine for Pseudohypoparathyroidism
To meet treatment goals, pseudohypoparathyroidism patients may require higher doses of levothyroxine and calcitriol than current guidelines recommend.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 19, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Can a Thyroid Hormone Medication Lift Depression and Dementia? Can a Thyroid Hormone Medication Lift Depression and Dementia?
Is the commonly prescribed levothyroxine a"poor man ' s option" for treating cognitive decline and low mood?Medscape Diabetes & Endocrinology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 16, 2021 Category: Neurology Tags: Diabetes & Endocrinology Commentary Source Type: news

Thyro-Tabs (Levothyroxine Sodium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 6, 2021 Category: Drugs & Pharmacology Source Type: news

Class 2 Medicines Recall: Accord-UK Ltd (Trading style: NorthStar), LEVOTHYROXINE TABLETS BP 50 micrograms EL (21)A/23
Accord-UK Ltd (Trading style: NorthStar) are recalling a specified batch of levothyroxine tablets BP 50 micrograms as a precautionary measure due to tablet hardness failures, leading to crumbling and (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 27, 2021 Category: Drugs & Pharmacology Source Type: news

Overuse of levothyroxine in the United States
One of the most common prescription drugs in America – levothyroxine – is used by people with underactive thyroid glands, also known as hypothyroidism. However, a new study by Mayo Clinic researchers says the majority of people were initiated on levothyroxine for mild subclinical hypothyroidism or for no apparent thyroid dysfunction. These results , published in JAMA Internal Medicine, suggest significant overuse of levothyroxine. Mayo researchers and colleagues examined retrospective, deidentified case data using the OptumLabs Data… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 28, 2021 Category: Databases & Libraries Source Type: news